Ignite Creation Date:
2025-12-24 @ 9:37 PM
Ignite Modification Date:
2025-12-25 @ 7:20 PM
Study NCT ID:
NCT04752332
Status:
TERMINATED
Last Update Posted:
2025-07-15
First Post:
2021-02-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-26
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-11
First Submit QC Date:
None
Study First Post Date:
2021-02-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-26
Results First Submit QC Date:
None
Results First Post Date:
2025-07-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-26
Last Update Post Date:
2025-07-15
Last Update Post Date Type:
ACTUAL